iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
GT 6 & 5 SVRs Harvoni & Future Gilead Therapies (daclatasvir Gt5 in vitro activity)
 
 
  GT 5 & 6
Harvoni GT4/5/6 - EASL/2015-GS9857/GS5816
http://www.natap.org/2015/HCV/090415_09.htm
 
High Efficacy of LDV/SOF Regimens for 12 Weeks for
Patients With HCV Genotype 3 or 6 Infection ELECTRON-2
 
http://www.natap.org/2014/AASLD/AASLD_21.htm

HCV1.gif

APASL/2013: Robust and Persistent Replication of Genotype 6a Hepatitis C Virus Replicon in Cell Culture - (06/12/13)

HCV2.gif

BMS-790052 is a First-in-class Potent Hepatitis C Virus (HCV) NS5A Inhibitor for Patients with Chronic HCV Infection: Results from a Proof-of-concept Study.......http://www.natap.org/2008/AASLD/AASLD_06.htm

HCV3.gif

  
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org